Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis

Table 1

Characteristics of 23 adult patients with mastocytosis.

Patient no.	Sex	Age	Disease category	Tryptase (μg/L)	Symptom grading
1	F	38	MIS	17.2	0
2	F	49	BMM	17.8	0
3	M	49	BMM	32.6	0
4	M	62	ISM	64.5	0
5	M	66	SSM	551	0
6	F	33	SM-AHD	7.9	0
7	F	29	MPCM	11.5	1
8	F	49	MPCM	5	1
9	F	26	MIS	15.8	1
10	F	45	MIS	47.6	1
11	M	50	MIS	127	1
12	M	54	SSM	216	1
13	M	57	ISM	58.4	1
14	F	42	ISM	184	2
15	F	49	ISM	56.5	2
16	M	71	ISM	17.6	2
17	M	50	SSM	454	2
18	F	57	SSM	112	2
19	M	35	ASM	145	2
20	F	35	ISM	32.4	3
21	F	55	ISM	129	3
22	F	45	ASM	36.2	3
23	M	76	ASM	390	3

ASM: aggressive systemic mastocytosis; BMM: bone marrow mastocytosis; ISM: indolent systemic mastocytosis; MIS: mastocytosis in the skin; MPCM: maculopapular cutaneous mastocytosis; SM-AHD: systemic mastocytosis associated with hematologic disease; SSM: smouldering systemic mastocytosis.